In Germany, in the early 70's, two projects dealing with the development of computer-assisted cervical screening were carried out. It was soon realized, however, that "machinereadable" cytological preparations had to fulfill certain criteria that were difficult to meet using conventional Pap smears: i. e. isolated cells in one optical plain (monolayer), high contrast between nuclei, cytoplasm and background and a clear background. The first issue was solved by the introduction of single cell preparation (monodispersion) and the latter by cell separation and cleansing. This was the advent of liquid based cytology (LBC). Currently, there are three LBC-systems used in Germany: the ThinPrep®, the SurePath® and the PapSpin® method. There are only very few differences between the cytomorphology of LBC and conventional Pap smears. The main difference is the clear background provided by LBC, which makes it easier to identify and interpret abnormal cells. So far, evidence suggests that liquid-based cytological methods offer the following advantages (Tab. 1, 2) compared to traditional smear techniques: a) a reduction in the proportion of inadequate specimens, b) an improvement in sensitivity, and c) a possible reduction in specimen interpretation times.
Introduction

! The science of liquid-based cytology is still in its infancy. I bet that George Papanicolaou would be its greatest fan (Leiman 2007). !
In 1943, Papanicolaou and Traut published the famous monography on vaginal cytology as a screening method for cervical cancer.The methods of Aurel Babes in Rumania (Tasca et al. 2002) were also documented during the same period.The technique of extracting cell samples from the cervix, streaking the cells onto a slide and their subsequent fixing, staining, and microscopic evaluation, has not altered greatly since then.The method has proven itself and has led to a decrease in the number of cervical carcinoma diagnosed in Germany. However, the major challenge that remains are the false-negative Pap tests, i. e. when the malignancy or its precursors remain undetected. Published studies dealing with the percentage of false-negative results have become a political issue in Germany: some claim a high false-negative rate (Schneider et al. 2000; Petry et al. 2003) while others can prove a low false-negative rate (Marquardt et al. 2005) .The truth probably lies somewhere in between. Based on meta-analyses, an international false-negative rate of about 50 % is assumed (Nanda et al. 2000) .This low sensitivity can be compensated by regular participation in screening.The possible causes of false-negative cytology are listed in table 3. • Cells are treated gently to avoid damage.
• Almost all smear test cells can be examined.
• Possibility to carry out other tests on the rest of the liquid (cytometry, immunocytochemistry, molecular pathology, cell block method).
• Cells are distributed randomly on the slide.
Disadvantages
• Greater demands on equipment and logistics.
• Cytological interpretation differs from conventional methods and users have got to be trained.
• The number of cells used in a BD SurePath TM Pap Test is not standardized; the staining process follows automatically. While the term "monodisperse cell separation" focuses on isolated mounting of the individual cells, the expression "monolayer preparation" emphasizes the fact that the cells lie in one plane. However, the liquid-based cytology technique does not yet meet these criteria: liquid-based cytology preparations contain more three-dimensional cell structures than those of conventional cytology, requiring the screener to constantly refocus (Fig. 2) . It is therefore consistent to replace the term monolayer cytology with thin-film or liquid-based cytology. It is difficult to standardize the preparatory steps, such as sampling the cells and transferring them onto the slides: over 80 % of the specimens taken are discarded together with the sampling device (Hutchinson et al. 1994) . The prepared smears demonstrate artistic variations (Fig. 1) . As described later on in this article, thin-film cytology provides a solution to the problem of standardizing cell transfer to slides. Screening errors (atypical cells are overlooked) can be avoided by computer-assisted screening.
The history of liquid-based cytology
In the 1970s, the German state financed two research projects on computer-assisted cervical screening: LEYTAS (Leyden Texture Analysis System) and FAZYTAN (automated early detection cytological analysis). During the projects, it became clear that if they were to be used with machines, the cytological preparations would have to fulfill certain criteria (Tab. 4). In Germany, this realization led to the development of single cell techniques and to cell separation and cleansing (see Tab. 5) as the main steps in liquid cytology (synonyms: thin-film cytology, monolayer cytology, liquid-based cytology). Ideally, the aim of the single cell technique (monodispersion) is to produce isolated cells in one optical layer (monolayer) and thus avoid the formation of cell clumps. Liquid-based cytology systems Three liquid cytology systems are presently available in Germany:ThinPrep® (Hologic), BD SurePath TM PapTest* (Becton Dickinson) and PapSpin® (ThermoShandon), and other similar methods (see below).
The main differences between the systems are shown in tables 5 and 6. The procedure for cell sampling is always the same: the instrument used for sampling is either thoroughly rinsed in the liquid (ThinPrep®), or the head of the instrument is removed at the predetermined breaking point and placed in the liquid (SurePath®). The manufacturers of the equipment provide training material on how to take the smear.
The composition of the liquids is patented and is therefore unknown. The liquids probably consist of buffered cell mediums with a relatively low alcohol content (methanol), as they must fulfill both the requirements of a cell transport medium and a cell fixative.
Aims of liquid cytology
• To recruit all exfoliated material for the cytological examination • Have method-immanent evidence on the cellularity as a quality assurance measure • Optimize visual morphological examination through an improved presentation of the material • Fulfill the criteria for computer-based screening • To temporarily document the material for further morphological and non-morphological examinations • Enable biomedical assistants to work more safely and in a less tiring manner, partly due to the elimination of disruptive elements (e.g. inflammatory cells, mucous, fibrin)
Production of cytological preparations
ThinPrep® (Hologic) Figure 3 shows the automated steps of the ThinPrep® method that take place in the T2000 Processor. Firstly, a rotating cylinder mechanically isolates the cells. Following this dispersion, the cells are filtered. The lower end of the cylinder is covered with a micropore filter and a vacuum is mounted at the upper end. The liquid containing the cells is thus sucked through the filter. The pores of the filter are large enough to allow neutrophil granulocytes and erythrocytes to pass, but too small to let epithelial cells pass. Gradually, epithelial cells obstruct the pores of the filter. The processor can detect when all the pores of the filter are obstructed and complete the filtration process. The filter is then thrown onto an electrically charged slide in order to transfer the cells onto the slide, which is stained in the following step. Single cell isolation (monodispersion)
Mechanical
• Vortexation (PapSpin®)
• Stirring (ThinPrep®)
• Filtration
• Cannulation (SurePath®)
• Homogenization and ultrasound 
SurePath® (Becton Dickinson)
This system is based on density gradient centrifugation (Fig. 4) . The sample containers are first vortexed, whereby single cells are isolated. An aliquot of the sample is placed into a centrifuge vial for density gradient centrifugation. In this process, the cells are separated according to their specific weight. Granulocytes, erythrocytes and debris that have a lower specific weight than the epithelial cells accumulate above the density gradient and are then discarded. Meanwhile, a pellet forms containing the cell population relevant for diagnosis; the pellet is resuspended and transferred onto a sedimentation chamber, which is mounted onto a slide. The cells sediment on the slide in thin layers and the rest of the liquid is discarded. Staining is an integral part of the process. The procedure described is not fully automated.
can be found in any position and are not grouped together in so-called streets, as observed in conventional preparations. The fields must therefore overlap in this type of screening. Additionally, screening of LBC preparations is altogether more intensive compared to conventional preparations, as atypical cells can be "hidden" in the gaps between the normal cells. Additionally, it is oftentimes necessary to change from the 10mm objective (screen enlargement) to the 40 mm lens to be able to precisely evaluate the solitary cells. Overall, the liquid-based cytology screening process requires greater concentration of the technician. Adequate cell number for liquid-based cytology preparations In the Bethesda Classification, 5000 cells are considered as adequate. McQueen and Duval (2006) were able to show that at least 87 atypical cells must be present in a preparation in order to detect them with certainty. However, according to mathematical calculations this can only be achieved with a total of 10 000 cells. In Wales, a limit of 15 000 cells has been established (Cervical Screening Wales 2006) . A study presently being carried out by the National Health Service (NHS) aims at solving the cell number issue for Great Britain. The cell number can only be correctly judged with a great amount of experience, thus having completed intensive training and use of comparative images (Solomon and Nayar 2004) .
Cell morphology of liquid-based cytological preparations in comparison to conventional preparations
Liquid-based cytology preparations are very similar to those of the regular smear method, although their morphology can sometimes differ fundamentally (Tab. 7). The most important difference -in comparison to regular methods -is the clear background of liquid cytology preparations, which enables an easy "visual access" to abnormal cells, thus facilitating their interpretation (Fig. 6 ). Despite this, it appears that these less expensive methods provide an alternative to the established methods if the preparations are carefully processed and if the cell content of the liquid is determined turbimetrically. This has been suggested by a study carried out at the John Hopkins Hospital, Baltimore (Rosenthal et al. 2006) . One can only hope that the manufacturers of the methods licensed by the FDA follow a different pricing policy in the future so that in Europe, the equipment becomes available at reasonable prices, as is the case in Belgium (ThinPrep®). We have to consider that the WHO only approves of less expensive methods for "mass screening". Correspondingly, the German Cytological Society (DGZ) is politically right when rejecting liquid-based cytology due to its high costs. However, it is surprising that a scientific society enlists the price of a method as an argument against its use.
Staining
On completion of the automated ThinPrep® process, the so produced unstained preparation can be stained using a variety of automatic staining apparatus. The author's own experience shows that it is advisable to slightly modify the staining protocol used for conventional smear preparations. In the SurePath® technique, staining is an integral part of the process, whereby the results of staining may differ from staining conventional preparations, especially with regard to the coloration of cytological cornifying processes. Keratinized cells are, however, an important marker both in detecting alterations caused by HPV as well as keratinized carcinomatous solitary cells. The fact that keratinized cells do not stain well led to a relatively poor rating for the SurePath® staining method in an external technical quality assurance program carried out in Great Britain (TEQA) (NHS CSP 2004) .
Screening methods for liquid-based cytology
The screening fields of the slide are round-shaped and much smaller than the fields in conventional preparations (Fig. 5) . Screening methods therefore differ from those used for conventional smear preparations: abnormal cells
Apart from the differing localization of atypical cells ("missing streets"), liquid-based cytology preparations also differ from conventional preparations in that there is less blood, fibrin, and necrotic debris on the slides due to their special processing. For many years, such artefacts have served as evidence for malignant processes in conventional cytology. Although this so-called tumor diathesis is also always found in preparations in liquid-based cytology, it is much more discreet and hangs like wallpaper on the surface of the cells and cell structures (Tab. 9). The squamous epithelial carcinoma should rather be recognized due to its characteristic morphology and not due to such debris (Tab. 10, Fig. 7a-d) . Glandular neoplasias also present a characteristic picture in thin-film cytology (Tab. 11, Fig. 8a-d) and are easily recognized. • Thus lower nuclear hyperchromasia Cytological details are well preserved in liquid-based cytology, for instance enabling the clear depiction of the nuclear chromatin. This has led to a renaissance of the "non-classical HPV signs", which had already been described many decades ago (Schneider et al. 1987) . • Chromatin is evenly distributed (cells appear "less malignant").
• Nucleoli are more prominent
• Malignant characteristics of the nucleus are preserved (pleomorphism in size and shape plus irregular contours of the nucleus)
Liquid-based cytology as a platform for the molecular Pap -a possibility for saving health care costs?
Apart from possible false-negative cytologies, another difficulty are the false-positive cytological findings, i. e. the low positive predictive value of cytology (ppv). The literature on the ppv of atypical cytologies shows results ranging from 11.4 % (Petry et al. 2003; Ronco et al. 2006 ) to 70.6 % (Schneider 2000) , with respect to the histological diagnosis ≥CIN II. In Germany, the follow-up costs to clarify findings and to treat nonspecific and abnormal findings found in cervix cytology amount to 55 million euro (Schneider et al. 2007) . A method that increases the ppv could therefore signify enormous savings:
• An increase in the ppv of just 1 % in cancer prevention cytology would spare 1 200 women from unnecessary treatment and save health care costs (Baak et al. 2005 ).
• One of the main measures taken to improve the ppv is HPV triage of atypical cytological findings. In our material we achieve a ppv of 82 % (Bollmann et al. 2005) . The costeffectiveness of HPV triage was established in a decisionanalytical model (Sheriff et al. 2007) . A further improvement in ppv is possible if HPV triage is combined with static DNA cytometry.
High-Risk HPV infection may lead to disruptions in the cell cycle and to chromosomal aneuploidy. 
Cytomorphology of HPV infection using liquid-based cytology
An infection with the human papilloma virus (HPV) damages the cell's cytoskeleton. A distinct cytoplasmic halo develops when the cytoskeleton collapses. This so-called koilocytosis (Greek: koilos = empty) is generally regarded as a classical HPV sign. There are, however, also discreet ("non-classical") HPV signs, which are particularly straightforward to recognize in LBC preparations: abortive koilocytosis, mild dyskeratosis, parakeratosis, mild nuclear hyperchromasia,"pointed" nuclei, grooved nuclei, multinuclear cells,"measle cells", keratohyalin-like granule cells, macrocytes and condensated cytoplasmic filaments ( Fig. 9a-f ). These secondary HPV signs have a negative predictive value of 100 %. If they are missing, it is highly probable that the woman is HPV negative (Bollmann et al. 2005) .
Based on our results, we are convinced that if these indications are rigorously examined, the cytological sensitivity increases. We also believe that the good results achieved when using liquid-based cytology are due to the improved (Sokolova et al. 2007 ).
Cytological correlation (cell block technique)
Liquid-based cytology allows the production of histological preparations using the so-called cell block technique (Gupta et al. 2007 ) (Fig. 10) . Liquid-based cytologies contain regular "mini-biopsies" (Yeoh u. Chan 1999) , on which good immunohistochemical tests can be performed. 
Validity
A pilot study carried out in England by the Department of Health on the introduction of liquid-based cytology showed that the number of unsuitable preparations decreased from 9.1 % (conventional) to 1.6 % (liquid-based cytology) (Moss et al. 2002) . In addition, screening had increased by 9 %. These results were sufficient reasons for including liquid-based cytology into England's cancer prevention program, even if the results of the pilot study could not prove the superior sensitivity of liquid-based cytology when compared to the conventional smear technique. In the meantime, official reports (also from Scotland) have confirmed an increase in the detection rate and a higher ppv (department of health) (Williams 2006) .
The FDA has established the following licensing guidelines for recognized methods: At present, there is no comparable licensing for PapSpin® or other thin-film techniques.
A meta-analysis recently published in the Lancet concludes that liquid-based cytology is no better than conventional cytology. The number of unsuitable cytological preparations was neither lower, nor was the detection rate of highgrade lesions higher (Davey et al. 2006) .
In an investigation carried out in Medline, the authors of the meta-analysis found 145 publications on the validity of liquid-based cytology. Of these publications, 116 (80 %!) were discarded, as they did not fulfill the inclusion criteria postulated by the authors of the meta-analysis. 27 other studies, which were not found in Medline, were added to the remaining 29 studies. Of the remaining 56 studies, none were found to be "ideal", 5 were judged to be of "high quality", 32 "intermediate quality" and 19 were "poor quality". The meta-analysis carried out by Davey and coworkers was based on the evaluation of 1.25 million slides. In conclusion, the meta-analysis does not support the proposition that liquid-based cytology produce better results and suggests that large randomized studies will have to be carried out.
When comparing the results of the study by Davey to those of the British study (Moss et al. 2002) , we can draw the conclusion that the good English results are based on a better training program for screeners: liquid-based cytology requires experience and the method cannot be used without training. The screener must be aware of the differences between the various methods. In England, liquid-based cytology has been available to all women via the National Health Service since the end of 2008. In the USA, 98 % of the Pap tests are liquid-based (Institute of Management and Administration 2007), as in the USA a reflex HPV test is required in the case of ASCUS ("atypical squamous cells of undetermined significance"). This test is carried out with the preserved liquid. Therefore it is not necessary to recall the patient in order to collect new samples.
Incidentally, the College of American Pathologists (CAP) has discovered that in the cytological examinations prescribed by the state ("proficiency program"), cytologists and cytological assistants significantly more often detect lesions when using liquid-based cytology compared to conventional preparations (Renshaw et al. 2004) .
It is regrettable that liquid-based cytology has led to a schism amongst cytologists with regard to the evaluation and use of the method and that the study by Davey has been greeted with such vehemence by the "partisans of The rigid stance of the German Society for Cytology is equally incomprehensible; the Society's statement on liquid-based cytology, issued in 2003, has still not been revised, even if members of the board of this scientific society, such as the head of the board of directors, regularly make use of the method (Bayer-Pietsch and Flenker 2004) . Above all, the DGZ considers the high costs of the tests and the financing of studies by the manufacturers as a reason for rejecting the method.To be consistent, the DGZ should also reject HPV vaccination, as it is financed by the industry and the vaccination is expensive. In contrast, the German HTA study (HTA: Health Technology Assessment; Siebert et al. 2003) came to the conclusion that the use of new screening technologies (thin-film preparation and computer-assisted evaluation methods) are acceptable per year of life saved, if screening takes place over a period of three or more years.
Computer-assisted screening Liquid-based cytology was advanced by the development of computer-assisted cytology. Nowadays, there are technically developed systems that can be used in everyday diagnostics. Becton-Dickinson Imaging (a subsidiary of SurePath) has developed the Focal Point and Focal Point GS System, which is now distributed by Becton-Dickinson. Besides preparations produced by the SurePath technique, the system also scans conventional preparations. A good smear technique is a prerequisite, as the computer is not able to read suboptimal cytological smear preparations. In order to produce optimal preparations for computerassisted systems, foam-based sampling devices can be used (e. g. Cervisoft®, PapCone®) (Bollmann et al. 2002) . The system identifies abnormal cells using an adaptive morphometric algorithm and sorts them according to the probability of being abnormal. 25 % of the preparations are classified as "no review" and can be issued as a negative result in the USA. The procedure is licensed by the FDA. However, in Germany, supplementary information has got to be documented, such as the degree of proliferation and microbiology. The preparations must therefore be evaluated by cytological assistants. In Germany, the system is used together with the Focal Point GS. Pictures of atypical cells are taken and their coordinates are stored. With the aid of a motorized microscope table, the 15 most abnormal cells are presented at the microscope for evaluation before the whole of the slide is conventionally screened. Focal Point GS has not yet been licensed by the FDA. 174
The coordinates of 22 cells with abnormal densitometric values are stored and after scanning, are presented on the microscope. Both methods are significantly more sensitive than manual screening, or at least as sensitive (Davey et al. 2007; Wilbur et al. 1998 Slight koilocytic dysplasias may be overlooked by TIS (Zhang et al. 2007) . It is possible that these cells do not differ densometrically from normal cells and are therefore not recognized by the system. In this regard, it should be mentioned that the percentage of invasive cervical carcinoma that are DNA-diploid is not low (Horn et al. 2002) .
Increased productivity
An English pilot study showed a 9 % increase in screening when using liquid-based cytology preparations (Moss et al. 2002) .This percentage is even higher when combined with computer-assisted methods (Wilbur et al. 1998; Davey et al. 2007 ).
Technical problems associated with the processing of liquid-based cytology preparations
Liquids containing a lot of mucous or blood can block the pores of the cell filter in the ThinPrep® method (Bentz et al. 2002) , producing preparations that are low in cell content and appear "moth-eaten" (Figure 11a, b) . In such cases, a second preparation must be processed after mucolysis or erythrolysis. The possibility of cell carryover is an additional problem with the ThinPrep® technique, if the preparation is not carefully processed. The cylinder with the cell filter naturally carries cells on its outer walls that were immersed in the preparation liquid. The used cylinder is unscrewed after preparation of the sample and is replaced by another filter. It must be ensured that no cells are transferred from the used to the new cylinder by using disposable gloves. In the SurePath® method, cells may be lost (FDA).
Costs of liquid-based cytology and billing modes
Thin-film preparation costs 29.03 euro while conventional cytology only costs 17.28 euro (the latter cost compares with an award of only 165 points for the EBM code number 01733!) (EBM = the so-called "Unique Evaluation Table" , Einheitlicher Bewertungsmaßstab) (Siebert et al. 2003) .
Following a ruling of the German Medical Association, liquid-based cytology is billed according to §6 GOÄ (Gebührenordnung für Ärzte -medical fee schedule) analogous with code number 4815. Fees can also be charged according to § 10 GOÄ. In the new draft of the GOÄ, one code number, which was not previously included, has been added for sample extraction.
Patients covered by the statutory health insurance can only be charged under the IGeL system (privately paid health services). In any case, it seems appropriate to use code number 1 GOÄ for consultancy fees. Many gynecologists and cytologists are of the opinion that the IGeL monolayer test should always simultaneously include a conventional smear, as otherwise the requirements of the services outlined in code number EBM 01733 are not fulfilled. Apart from the fact that the purpose of liquid-based tests is thwarted by such procedure, the above-mentioned interpretation is, in the author's opinion, incorrect. The service legend for EBM code 01733, used for billing cytological examinations according to Section B.2 of the cancer prevention guidelines, stipulates the obligatory content as "cytological examination of one or more smears, also brush smears, of the ecto-and/or endocervix." Many gynecologists and cytologists automatically equate the expression "smear" with the application of the sample material to the slide. The author cannot follow this line of argumentation: a smear is the removal of bodily material from the surface of a wound or mucous membrane (mouth, urethra, vagina, anus) using a sterile swab, small brushes, or small spatula for the purpose of examination".
The cancer prevention guidelines (last altered on 01.12.2003) state:"Cytological examination includes the evaluation of material removed for the purpose of cytological examination". How to preserve the material is not prescribed. Consequently, transferring the sample material to a liquid medium as an alternative to the regular processing of slide-based preparations is not excluded. The latest resolution of the Federal Committee of the 19.12.2006 also does not explicitly forbid the use of liquid-based cytology:"In its meeting on the 19.12.2006, the Federal Committee decided that thin-film cytology and HPV test methods will not be implemented as a cancer prevention screening test for cervical carcinoma."
The expression "will not be employed" does not indicate that thin-film cytology is not an approved method; in fact, the committee simply decided not to implement the method at present. It is not expressly forbidden to bill liquidbased cytological examinations under the code for preventive examinations. Only the preparation process has got to be billed as a privately paid service (IGeL).
